156 related articles for article (PubMed ID: 33264019)
21. Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter.
Zheng G; Dwoskin LP; Deaciuc AG; Norrholm SD; Crooks PA
J Med Chem; 2005 Aug; 48(17):5551-60. PubMed ID: 16107155
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antitumor activity of ring A- and F-modified hexacyclic camptothecin analogues.
Sugimori M; Ejima A; Ohsuki S; Uoto K; Mitsui I; Kawato Y; Hirota Y; Sato K; Terasawa H
J Med Chem; 1998 Jun; 41(13):2308-18. PubMed ID: 9632364
[TBL] [Abstract][Full Text] [Related]
23. Effect of A-ring modifications on the DNA-binding behavior and cytotoxicity of pyrrolo[2,1-c][1,4]benzodiazepines.
Thurston DE; Bose DS; Howard PW; Jenkins TC; Leoni A; Baraldi PG; Guiotto A; Cacciari B; Kelland LR; Foloppe MP; Rault S
J Med Chem; 1999 Jun; 42(11):1951-64. PubMed ID: 10354403
[TBL] [Abstract][Full Text] [Related]
24. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.
Sakoff JA; Ackland SP; Baldwin ML; Keane MA; McCluskey A
Invest New Drugs; 2002 Feb; 20(1):1-11. PubMed ID: 12003183
[TBL] [Abstract][Full Text] [Related]
25. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
Medarde M; Maya AB; Pérez-Melero C
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):521-40. PubMed ID: 15662956
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.
Congiu C; Cocco MT; Onnis V
Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978
[TBL] [Abstract][Full Text] [Related]
27. Modification of imidazothiazole derivatives gives promising activity in B-Raf kinase enzyme inhibition; synthesis, in vitro studies and molecular docking.
Ammar UM; Abdel-Maksoud MS; Mersal KI; Ali EMH; Yoo KH; Choi HS; Lee JK; Cha SY; Oh CH
Bioorg Med Chem Lett; 2020 Oct; 30(20):127478. PubMed ID: 32781217
[TBL] [Abstract][Full Text] [Related]
28. Ionic Liquid-Promoted Synthesis of Novel Chromone-Pyrimidine Coupled Derivatives, Antimicrobial Analysis, Enzyme Assay, Docking Study and Toxicity Study.
Tiwari SV; Seijas JA; Vazquez-Tato MP; Sarkate AP; Karnik KS; Nikalje APG
Molecules; 2018 Feb; 23(2):. PubMed ID: 29462951
[TBL] [Abstract][Full Text] [Related]
29. Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation.
Eissa IH; El-Helby AA; Mahdy HA; Khalifa MM; Elnagar HA; Mehany ABM; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; El-Adl K
Bioorg Chem; 2020 Dec; 105():104380. PubMed ID: 33128967
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of artemisinic acid derived glycoconjugates and their anticancer studies.
Kotammagari TK; Paul S; Barik GK; Santra MK; Bhattacharya AK
Org Biomol Chem; 2020 Mar; 18(12):2252-2263. PubMed ID: 32149317
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Pyrano[3,2 C] Quinoline Analogues as Anticancer Agents.
Upadhyay KD; Shah AK
Anticancer Agents Med Chem; 2019; 19(10):1285-1292. PubMed ID: 30854977
[TBL] [Abstract][Full Text] [Related]
32. Total synthesis and biological evaluation of (+)-gambieric acid A and its analogues.
Ishigai K; Fuwa H; Hashizume K; Fukazawa R; Cho Y; Yotsu-Yamashita M; Sasaki M
Chemistry; 2013 Apr; 19(17):5276-88. PubMed ID: 23554126
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives.
Maryanoff BE; Costanzo MJ; Nortey SO; Greco MN; Shank RP; Schupsky JJ; Ortegon MP; Vaught JL
J Med Chem; 1998 Apr; 41(8):1315-43. PubMed ID: 9548821
[TBL] [Abstract][Full Text] [Related]
35. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
36. Ipomoeassin F, a new cytotoxic macrocyclic glycoresin from the leaves of Ipomoea squamosa from the Suriname rainforest.
Cao S; Norris A; Wisse JH; Miller JS; Evans R; Kingston DG
Nat Prod Res; 2007 Aug; 21(10):872-6. PubMed ID: 17680496
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and in vitro biological activity of new deaza analogues of folic acid, aminopterin, and methotrexate with an L-ornithine side chain.
Rosowsky A; Forsch RA; Bader H; Freisheim JH
J Med Chem; 1991 Apr; 34(4):1447-54. PubMed ID: 2016722
[TBL] [Abstract][Full Text] [Related]
38. Design, Synthesis and Biological Evaluation of a Structurally Simplified Syringolin A Analogues.
Chiba T; Kitahata S; Matsuda A; Ichikawa S
Chem Pharm Bull (Tokyo); 2016; 64(7):811-6. PubMed ID: 27373636
[TBL] [Abstract][Full Text] [Related]
39. Potent colchicine-site ligands with improved intrinsic solubility by replacement of the 3,4,5-trimethoxyphenyl ring with a 2-methylsulfanyl-6-methoxypyridine ring.
Álvarez R; Aramburu L; Gajate C; Vicente-Blázquez A; Mollinedo F; Medarde M; Peláez R
Bioorg Chem; 2020 May; 98():103755. PubMed ID: 32200330
[TBL] [Abstract][Full Text] [Related]
40. The synthesis and cholinesterase inhibitory activities of solasodine analogues with seven-membered F ring.
Kiełczewska U; Jorda R; Gonzalez G; Morzycki JW; Ajani H; Svrčková K; Štěpánková Š; Wojtkielewicz A
J Steroid Biochem Mol Biol; 2021 Jan; 205():105776. PubMed ID: 33130020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
